Recent Events & Catalysts
Scholar Rock Holding Corporation (SRRK) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
No committee signals recorded yet.
News
Scholar Rock Overcomes Manufacturing Hurdle to Keep Lead Drug FDA Review on Schedule
Benzinga · 1d ago
Wedbush Reiterates Outperform on Scholar Rock Holding, Maintains $58 Price Target
Benzinga · 1d ago
HC Wainwright & Co. Reiterates Buy on Scholar Rock Holding, Maintains $65 Price Target
Benzinga · 1d ago
Citigroup Maintains Buy on Scholar Rock Holding, Raises Price Target to $60
Benzinga · 4d ago
Scholar Rock Removes Catalent Indiana From Apitegromab BLA After FDA OAI Classification; FDA Review Remains On Track for Sept. 30 PDUFA Using Second Fill-Finish Site
Benzinga · 4d ago
Scholar Rock (NASDAQ:SRRK) Rallies 17% as Regulatory Catalysts Outweigh In-Line Q2 Results
ChartMill · 5d ago
Scholar Rock Holding Corporation (SRRK) Q2 2026 Earnings Call Transcript
SeekingAlpha · 5d ago
Scholar Rock Holding Q2 EPS $(0.84) Beats $(0.85) Estimate; Cash Balance Of $492M
Benzinga · 5d ago
SEC Filings (90 days)
Other events, Financial statements and exhibits
Filed 2026-08-06 · 5d ago
Results of operations (earnings release)
Filed 2026-08-06 · 5d ago · Material
Submission of matters to a vote of security holders
Filed 2026-06-05 · 67d ago
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.